Literature DB >> 24762312

Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.

Anuja Mathew1, Elizabeth Townsley, Francis A Ennis.   

Abstract

Dengue viruses (DENV) cause significantly more human disease than any other arbovirus, with hundreds of thousands of cases leading to severe disease in thousands annually. Antibodies and T cells induced by primary infection with DENV have the potential for both positive (protective) and negative (pathological) effects during subsequent DENV infections. In this review, we summarize studies that have examined T-cell responses in humans following natural infection and vaccination. We discuss studies that support a role for T cells in protection against and those that support a role for the involvement of T cells in the pathogenesis of severe disease. The mechanisms that lead to severe disease are complex, and T-cell responses are an important component that needs to be further evaluated for the development of safe and efficacious DENV vaccines.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24762312      PMCID: PMC4113002          DOI: 10.2217/fmb.13.171

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  102 in total

Review 1.  Immunopathological mechanisms in dengue and dengue hemorrhagic fever.

Authors:  Sharone Green; Alan Rothman
Journal:  Curr Opin Infect Dis       Date:  2006-10       Impact factor: 4.915

Review 2.  Humanized mice for immune system investigation: progress, promise and challenges.

Authors:  Leonard D Shultz; Michael A Brehm; J Victor Garcia-Martinez; Dale L Greiner
Journal:  Nat Rev Immunol       Date:  2012-10-12       Impact factor: 53.106

3.  Antibodies from patients with dengue viral infection mediate cellular cytotoxicity.

Authors:  G García; M Arango; A B Pérez; L Fonte; B Sierra; R Rodríguez-Roche; E Aguirre; I Fiterre; M G Guzmán
Journal:  J Clin Virol       Date:  2006-06-19       Impact factor: 3.168

4.  Tumor necrosis factor-alpha, transforming growth factor-β1, and interleukin-10 gene polymorphisms: implication in protection or susceptibility to dengue hemorrhagic fever.

Authors:  Ana B Perez; Beatriz Sierra; Gissel Garcia; Eglis Aguirre; Nina Babel; Mayling Alvarez; Licel Sanchez; Luis Valdes; Hans D Volk; Maria G Guzman
Journal:  Hum Immunol       Date:  2010-08-21       Impact factor: 2.850

Review 5.  Critical issues in dengue vaccine development.

Authors:  Stephen J Thomas; Timothy P Endy
Journal:  Curr Opin Infect Dis       Date:  2011-10       Impact factor: 4.915

Review 6.  Immunity and immunopathology in dengue virus infections.

Authors:  I Kurane; F E Ennis
Journal:  Semin Immunol       Date:  1992-04       Impact factor: 11.130

7.  The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response.

Authors:  Rama S Akondy; Nathan D Monson; Joseph D Miller; Srilatha Edupuganti; Dirk Teuwen; Hong Wu; Farah Quyyumi; Seema Garg; John D Altman; Carlos Del Rio; Harry L Keyserling; Alexander Ploss; Charles M Rice; Walter A Orenstein; Mark J Mulligan; Rafi Ahmed
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

8.  Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells.

Authors:  Zhihua Kou; Matthew Quinn; Huiyuan Chen; W W Shanaka I Rodrigo; Robert C Rose; Jacob J Schlesinger; Xia Jin
Journal:  J Med Virol       Date:  2008-01       Impact factor: 2.327

9.  Dengue virus protein recognition by virus-specific murine CD8+ cytotoxic T lymphocytes.

Authors:  A L Rothman; I Kurane; C J Lai; M Bray; B Falgout; R Men; F A Ennis
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

10.  Identification of a dengue virus-specific HLA-A*0201-restricted CD8+ T cell epitope.

Authors:  Jinsheng Wen; Zhiliang Duan; Lifang Jiang
Journal:  J Med Virol       Date:  2010-04       Impact factor: 2.327

View more
  26 in total

Review 1.  Humanized mouse models to study human cell-mediated and humoral responses to dengue virus.

Authors:  Anuja Mathew
Journal:  Curr Opin Virol       Date:  2017-08-09       Impact factor: 7.090

2.  Bridging Efficacy of a Tetravalent Dengue Vaccine from Children/Adolescents to Adults in Highly Endemic Countries Based on Neutralizing Antibody Response.

Authors:  Peter B Gilbert; Ying Huang; Michal Juraska; Zoe Moodie; Youyi Fong; Alexander Luedtke; Yingying Zhuang; Jason Shao; Lindsay N Carpp; Nicholas Jackson; Laurent Chambonneau; Alain Bouckenooghe; Betzana Zambrano; Carina Frago; Sophie Pallardy; Fernando Noriega
Journal:  Am J Trop Med Hyg       Date:  2019-07       Impact factor: 2.345

3.  Human T Lymphocytes Are Permissive for Dengue Virus Replication.

Authors:  Guilherme F Silveira; Pryscilla F Wowk; Allan H D Cataneo; Paula F Dos Santos; Murilo Delgobo; Marco A Stimamiglio; Maria Lo Sarzi; Ana Paula F S Thomazelli; Ivete Conchon-Costa; Wander R Pavanelli; Lis R V Antonelli; André Báfica; Daniel S Mansur; Claudia N Duarte Dos Santos; Juliano Bordignon
Journal:  J Virol       Date:  2018-04-27       Impact factor: 5.103

4.  T-cells producing multiple combinations of IFNγ, TNF and IL10 are associated with mild forms of dengue infection.

Authors:  Marcela Helena Gonçalves Pereira; Maria Marta Figueiredo; Camila Pereira Queiroz; Télcia Vasconcelos Barros Magalhães; Adriana Mafra; Lilian Martins Oliveira Diniz; Último Libânio da Costa; Kenneth J Gollob; Lis Ribeiro do Valle Antonelli; Helton da Costa Santiago
Journal:  Immunology       Date:  2020-04-06       Impact factor: 7.397

5.  A novel immunization approach for dengue infection based on conserved T cell epitopes formulated in calcium phosphate nanoparticles.

Authors:  Xiaofang Huang; Aykan Karabudak; Joseph D Comber; Mohan Philip; Tulin Morcol; Ramila Philip
Journal:  Hum Vaccin Immunother       Date:  2017-09-21       Impact factor: 3.452

Review 6.  Nucleic Acid Vaccine Platform for DENGUE and ZIKA Flaviviruses.

Authors:  Jarin Taslem Mourosi; Ayobami Awe; Swati Jain; Himanshu Batra
Journal:  Vaccines (Basel)       Date:  2022-05-24

Review 7.  Innate immune receptors drive dengue virus immune activation and disease.

Authors:  Joris Sprokholt; Leanne C Helgers; Teunis Bh Geijtenbeek
Journal:  Future Virol       Date:  2017-11-17       Impact factor: 1.831

8.  Nonstructural Proteins Are Preferential Positive Selection Targets in Zika Virus and Related Flaviviruses.

Authors:  Manuela Sironi; Diego Forni; Mario Clerici; Rachele Cagliani
Journal:  PLoS Negl Trop Dis       Date:  2016-09-02

9.  Interaction of a dengue virus NS1-derived peptide with the inhibitory receptor KIR3DL1 on natural killer cells.

Authors:  E Townsley; G O'Connor; C Cosgrove; M Woda; M Co; S J Thomas; S Kalayanarooj; I-K Yoon; A Nisalak; A Srikiatkhachorn; S Green; H A F Stephens; E Gostick; D A Price; M Carrington; G Alter; D W McVicar; A L Rothman; A Mathew
Journal:  Clin Exp Immunol       Date:  2015-11-24       Impact factor: 4.330

Review 10.  New insights into the immunopathology and control of dengue virus infection.

Authors:  Gavin Screaton; Juthathip Mongkolsapaya; Sophie Yacoub; Catherine Roberts
Journal:  Nat Rev Immunol       Date:  2015-12       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.